过去一年中添加的文章,按日期排序
A novel anti-CD47 protein antibody and toll-like receptor agonist complex detects tumor surface CD-47 changes in early stage lung cancer by in vivo imaging
Y Xu, L Gu, L Zhu, Y Miao, X Cui - International Journal of Biological …, 2024 - Elsevier
5 天前 - … accurate assessments of various analytes, providing valuable data for our research.
… the end of treatment, animal live imaging was performed to assess treatment efficacy.(B)…
… the end of treatment, animal live imaging was performed to assess treatment efficacy.(B)…
[HTML][HTML] Efficacy of Xuebijing Injection for the Treatment of Acute Lung Injury: A Meta-analysis of Randomized Controlled Trials
L Dai, M Chen, Q Chen, Y Zhuang, H Jiang, Y Xu - Heliyon, 2024 - Elsevier
5 天前 - … research is lacking, which limits the clinical use of Xuebijing injection for the treatment
… systematically evaluated the efficacy of Xuebijing injection in the treatment of patients …
… systematically evaluated the efficacy of Xuebijing injection in the treatment of patients …
[HTML][HTML] Morpho-constitutional analysis of urolithiasis and in vitro litholytic evaluation of select plants against diverse renal calculi variants
A Belhachem, S Makhloufi… - African Journal of …, 2024 - afju.springeropen.com
5 天前 - … , this investigation aims to assess their efficacy in dissolving different types of calculi.
… This research offers safer and more accessible treatment options, especially in regions …
… This research offers safer and more accessible treatment options, especially in regions …
QOL-01. FEASIBILITY AND EFFICACY OF DIETARY AND LIFESTYLE INTERVENTIONS FOR HYPOTHALAMIC OBESITY DURING CHILDHOOD: A SYSTEMATIC …
I van Roessel, M van den Brink, J Dekker… - Neuro …, 2024 - ncbi.nlm.nih.gov
5 天前 - … or after (treatment of) a suprasellar tumor. There is currently no effective treatment
for … lifestyle interventions are the cornerstone of obesity treatment. The obesity in patients with …
for … lifestyle interventions are the cornerstone of obesity treatment. The obesity in patients with …
MDB-97. INVESTIGATING THE IMMUNOMODULATORY ROLE OF V-DOMAIN IG SUPPRESSOR OF T-CELL ACTIVATION IN AN AGGRESSIVE MURINE MODEL OF …
NAM Perez, J Pensabene, K Moziak, R Yazejian… - Neuro …, 2024 - ncbi.nlm.nih.gov
5 天前 - … However, significant barriers to treatment efficacy include low numbers of infiltrating
effector T-cells and paucity of PD-L1 expression in the tumor microenvironment. Thus, …
effector T-cells and paucity of PD-L1 expression in the tumor microenvironment. Thus, …
DIPG-15. NOVEL CNS SENSING SYNNOTCH-CAR T CELLS FOR TARGETING DIFFUSE MIDLINE GLIOMA
S Lakshmanachetty, M Simic, J Haegelin… - Neuro …, 2024 - ncbi.nlm.nih.gov
5 天前 - … brain tumor in children with limited treatment options. Recent developments of phase
1 clinical … of clinical trials evaluating the efficacy of B-SYNC T cells in DMG/DIPG patients. …
1 clinical … of clinical trials evaluating the efficacy of B-SYNC T cells in DMG/DIPG patients. …
IMMU-21. B7-H3 NANOBODY CAR-T CELL THERAPY IN PEDIATRIC GLIOBLASTOMA
M Fanuzzi, MP Singh, M Puebla, A Cole, D Li… - Neuro …, 2024 - ncbi.nlm.nih.gov
5 天前 - … Immunotherapy is a developing but challenging field of research for the treatment
of central … In vivo studies are evaluating the efficacy of B7-H3 CAR-T cells in an orthotopic …
of central … In vivo studies are evaluating the efficacy of B7-H3 CAR-T cells in an orthotopic …
IMMU-05. TARGETING THE DYSREGULATED DNA METHYLOME DURING CAR T CELL MANUFACTURING IMPROVES THEIR FITNESS IN IMMUNOCOMPETENT …
Z Yi, E VanNoy, A Lee, D Haydar - Neuro-Oncology, 2024 - ncbi.nlm.nih.gov
5 天前 - … DNA methylome in engineered immune cells can improve their anti-tumor efficacy.
… This study proposes that DNMTi pre-treatment may offer a promising approach for optimizing …
… This study proposes that DNMTi pre-treatment may offer a promising approach for optimizing …
MDB-86. ISOTRETINOIN HAS NO EFFECT ON EVENT FREE SURVIVAL ACROSS HIGH-RISK MEDULLOBLASTOMA MOLECULAR SUBGROUPS WHEN ADDED …
SI Raskin, PMK de Blank, CA Billups, Y Li… - Neuro …, 2024 - ncbi.nlm.nih.gov
5 天前 - BACKGROUND Medulloblastoma has been redefined into four molecular subgroups
(WNT, SHH, Group 3, and Group 4), with distinct prognoses and responses to treatment. …
(WNT, SHH, Group 3, and Group 4), with distinct prognoses and responses to treatment. …
DIPG-39. ONCOHISTONE H3. 3K27M-DRIVEN CREB5/ID1 AXIS DICTATES THE MALIGNANT CELL STATES OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
5 天前 - … efficacy in treating DIPG. Additionally, the combination of a compound targeting
the CREB5/ID1 axis and a BRG1 inhibitor shows promise for DIPG treatment. … This research …
the CREB5/ID1 axis and a BRG1 inhibitor shows promise for DIPG treatment. … This research …